Opportunities and challenges in closed-loop systems in type 1 diabetes.
作者信息
Wilson Leah M, Jacobs Peter G, Riddell Michael C, Zaharieva Dessi P, Castle Jessica R
机构信息
Division of Endocrinology, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University, Portland, OR 97239, USA.
Artificial Intelligence for Medical Systems Lab, Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA.
出版信息
Lancet Diabetes Endocrinol. 2022 Jan;10(1):6-8. doi: 10.1016/S2213-8587(21)00289-8. Epub 2021 Nov 8.
Abstract
摘要
相似文献
1
Opportunities and challenges in closed-loop systems in type 1 diabetes.1型糖尿病闭环系统中的机遇与挑战
Lancet Diabetes Endocrinol. 2022 Jan;10(1):6-8. doi: 10.1016/S2213-8587(21)00289-8. Epub 2021 Nov 8.
2
Closed-loop in children with type 1 diabetes: specific challenges.闭环管理在 1 型糖尿病患儿中的应用：具体挑战。
Diabetes Res Clin Pract. 2011 Aug;93 Suppl 1:S131-5. doi: 10.1016/S0168-8227(11)70029-8.
3
New closed-loop insulin systems.新型闭环胰岛素系统。
Diabetologia. 2021 May;64(5):1007-1015. doi: 10.1007/s00125-021-05391-w. Epub 2021 Feb 6.
4
Behavioural implications of traditional treatment and closed-loop automated insulin delivery systems in Type 1 diabetes: applying a cognitive restraint theory framework.1 型糖尿病中传统治疗和闭环自动化胰岛素输送系统的行为学影响：应用认知约束理论框架。
Diabet Med. 2017 Nov;34(11):1500-1507. doi: 10.1111/dme.13407. Epub 2017 Sep 11.
5
Closing the Loop on Exercise in Type 1 Diabetes.1型糖尿病运动闭环管理
Curr Diabetes Rev. 2018;14(3):257-265. doi: 10.2174/1573399813666170228121604.
6
Long-term application of wearable artificial endocrine pancreas--closed-loop intravenous vs subcutaneous insulin infusion.可穿戴人工内分泌胰腺的长期应用——闭环静脉注射与皮下胰岛素输注对比
Life Support Syst. 1985;3 Suppl 1:583-7.
7
What Training, Support, and Resourcing Do Health Professionals Need to Support People Using a Closed-Loop System? A Qualitative Interview Study with Health Professionals Involved in the Closed Loop from Onset in Type 1 Diabetes (CLOuD) Trial.卫生专业人员需要哪些培训、支持和资源来支持闭环系统使用者？一项与参与 1 型糖尿病闭环试验（CLOuD）的闭环起始阶段卫生专业人员有关的定性访谈研究。
Diabetes Technol Ther. 2020 Jun;22(6):468-475. doi: 10.1089/dia.2019.0466. Epub 2020 Mar 6.
8
Pharmacological aspects of closed loop insulin delivery for type 1 diabetes.闭环胰岛素输送在 1 型糖尿病中的药理学方面。
Curr Opin Pharmacol. 2017 Oct;36:29-33. doi: 10.1016/j.coph.2017.07.006. Epub 2017 Aug 10.
9
Closed-loop control in type 1 diabetes.1型糖尿病的闭环控制
Lancet Diabetes Endocrinol. 2016 Mar;4(3):191-193. doi: 10.1016/S2213-8587(16)00015-2. Epub 2016 Feb 3.
10
Is an artificial pancreas (closed-loop system) for Type 1 diabetes effective?1 型糖尿病的人工胰腺（闭环系统）有效吗？
Diabet Med. 2019 Mar;36(3):279-286. doi: 10.1111/dme.13816. Epub 2018 Oct 16.
引用本文的文献
1
Ethical gaps in closed-loop neurotechnology: a scoping review.闭环神经技术中的伦理差距：一项范围综述。
NPJ Digit Med. 2025 Aug 8;8(1):510. doi: 10.1038/s41746-025-01908-4.
2
Early Detection of Elevated Ketone Bodies in Type 1 Diabetes Using Insulin and Glucose Dynamics Across Age Groups: Model Development Study.利用各年龄组胰岛素和葡萄糖动态变化早期检测1型糖尿病患者酮体升高：模型开发研究
JMIR Diabetes. 2025 Apr 10;10:e67867. doi: 10.2196/67867.
3
[Research progress on automated insulin delivery system in the field of diabetes management].[糖尿病管理领域自动胰岛素输送系统的研究进展]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2024 Dec 25;41(6):1279-1285. doi: 10.7507/1001-5515.202406060.
4
Efficacy and Safety of Automated Insulin Delivery Systems in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.1型糖尿病患者自动胰岛素给药系统的疗效和安全性：一项系统评价和荟萃分析。
Diabetes Metab J. 2025 Mar;49(2):235-251. doi: 10.4093/dmj.2024.0130. Epub 2024 Nov 13.
5
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead.利用细胞疗法治疗1型糖尿病：进展、挑战与未来之路。
Nat Rev Endocrinol. 2025 Jan;21(1):14-30. doi: 10.1038/s41574-024-01029-0. Epub 2024 Sep 3.
6
Glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system 2-year prospective, observational, two-center study.使用先进的混合闭环系统治疗 1 型糖尿病儿童的血糖控制：为期 2 年的前瞻性、观察性、两中心研究。
Front Endocrinol (Lausanne). 2024 Feb 8;15:1332418. doi: 10.3389/fendo.2024.1332418. eCollection 2024.
7
Integrating metabolic expenditure information from wearable fitness sensors into an AI-augmented automated insulin delivery system: a randomised clinical trial.将可穿戴健身传感器的代谢消耗信息整合到人工智能增强型自动胰岛素输送系统中：一项随机临床试验。
Lancet Digit Health. 2023 Sep;5(9):e607-e617. doi: 10.1016/S2589-7500(23)00112-7. Epub 2023 Aug 3.
8
Wearable Insulin Biosensors for Diabetes Management: Advances and Challenges.可穿戴胰岛素生物传感器在糖尿病管理中的应用：进展与挑战。
Biosensors (Basel). 2023 Jul 7;13(7):719. doi: 10.3390/bios13070719.
9
Quantifying insulin-mediated and noninsulin-mediated changes in glucose dynamics during resistance exercise in type 1 diabetes.量化 1 型糖尿病患者抗阻运动过程中胰岛素介导和非胰岛素介导的血糖动力学变化。
Am J Physiol Endocrinol Metab. 2023 Sep 1;325(3):E192-E206. doi: 10.1152/ajpendo.00298.2022. Epub 2023 Jul 12.
10
Meal and Physical Activity Detection from Free-living Data for Discovering Disturbance Patterns to Glucose Levels in People with Diabetes.从自由生活数据中检测饮食和身体活动，以发现糖尿病患者血糖水平的干扰模式。
BioMedInformatics. 2022 Jun;2(2):297-317. doi: 10.3390/biomedinformatics2020019. Epub 2022 Jun 1.
本文引用的文献
1
Standardized Hybrid Closed-Loop System Reporting.标准化混合闭环系统报告。
Diabetes Technol Ther. 2021 May;23(5):323-331. doi: 10.1089/dia.2020.0622. Epub 2020 Nov 25.
2
Racial-Ethnic Disparities in Diabetes Technology use Among Young Adults with Type 1 Diabetes.1 型糖尿病青年患者中糖尿病技术使用的种族-民族差异。
Diabetes Technol Ther. 2021 Apr;23(4):306-313. doi: 10.1089/dia.2020.0338. Epub 2020 Dec 1.
3
Accuracy of the Dexcom G6 Glucose Sensor during Aerobic, Resistance, and Interval Exercise in Adults with Type 1 Diabetes.德康 G6 葡萄糖传感器在 1 型糖尿病成人有氧运动、抗阻运动和间歇运动期间的准确性。
Biosensors (Basel). 2020 Sep 29;10(10):138. doi: 10.3390/bios10100138.
4
Assessing Mealtime Macronutrient Content: Patient Perceptions Versus Expert Analyses via a Novel Phone App.评估用餐时的宏量营养素含量：通过新型手机应用程序评估患者感知与专家分析。
Diabetes Technol Ther. 2021 Feb;23(2):85-94. doi: 10.1089/dia.2020.0357. Epub 2020 Sep 29.
5
An artificial intelligence decision support system for the management of type 1 diabetes.用于 1 型糖尿病管理的人工智能决策支持系统。
Nat Metab. 2020 Jul;2(7):612-619. doi: 10.1038/s42255-020-0212-y. Epub 2020 Jun 1.
6
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.1 型糖尿病闭环控制的 6 个月随机、多中心试验。
N Engl J Med. 2019 Oct 31;381(18):1707-1717. doi: 10.1056/NEJMoa1907863. Epub 2019 Oct 16.
7
International Consensus on Use of Continuous Glucose Monitoring.连续血糖监测应用的国际共识
Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600.
8
Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.1型糖尿病患者使用混合闭环胰岛素输送系统的安全性。
JAMA. 2016 Oct 4;316(13):1407-1408. doi: 10.1001/jama.2016.11708.
9
Impaired absorption of insulin aspart from lipohypertrophic injection sites.来自脂肪增生注射部位的门冬胰岛素吸收受损。
Diabetes Care. 2005 Aug;28(8):2025-7. doi: 10.2337/diacare.28.8.2025.
Zotero 插件